SCHEMBL25490941

SCHEMBL25490941

Cc1ccc(C(=O)NC(C(=O)NC(C)C(=O)Nc2ccc(COC(N)=O)cc2)C(C)C)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.49
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ USP2 O75604 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ PLAU P00749 2/20 0.42
▸ HPN P05981 2/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ LMNA P02545 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ ERAP2 Q6P179 1/20 0.40
▸ LNPEP Q9UIQ6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384476 0.91 USP2 (0.47) HTTNPC1RAB9AUSP2SMN1; SMN2
SCHEMBL25561581 0.86 USP2 (0.43) HTTNPC1RAB9AUSP2SMN1; SMN2
SCHEMBL14870877 0.84 SMN1; SMN2 (0.49) HTTNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL27385413 0.84 HTT (0.44) HTTNPC1RAB9AUSP2SMN1; SMN2
SCHEMBL19633842 0.83 SMN1; SMN2 (0.48) HTTNPC1RAB9ASMN1; SMN2PLAU
SCHEMBL12698542 0.82 HTT (0.48) HTTNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL23071857 0.80 KMT2A (0.42) HTTNPC1RAB9AUSP2SMN1; SMN2
SCHEMBL24252193 0.79 SMN1; SMN2 (0.51) HTTNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL23432921 0.78 HTT (0.39) HTTNPC1RAB9AUSP2SMN1; SMN2
SCHEMBL25489515 0.78 HTT (0.46) HTTUSP2PLAUHPNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158154-A1 CONJUGATES COMPRISING A PHOSPHORUS (V) AND A CAMPTOTHECIN MOIETY TUBULIS GMBH (DE) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158154-A1 CONJUGATES COMPRISING A PHOSPHORUS (V) AND A CAMPTOTHECIN MOIETY CALCR, PTH1R, BCR HTT 4221/4885NPC1 3030/4885RAB9A 805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback